DUBLIN, October 5, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Cell Analysis Market 2016-2020" report to their offering.
The global cell analysis market to grow at a CAGR of 7.08% during the period 2016-2020.
Global Cell Analysis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The repoTo calculate the market size, the report considers the revenue generated from the sale of the instruments, and consumables. rt also includes a discussion of the key vendors operating in this market.
Increasing number of diagnostic centers will be a key trend for market growth. An ever-changing consumer demand has resulted in shifting diagnostic testing from hospitals and commercial laboratories closer to the patients' homes, which lessens the cost of testing. However, in many countries, most of the healthcare services delivered are primarily for urban areas with a very less focus on rural areas. Many developing countries have a high percentage of people living in the rural areas where diagnostic centers are fewer and have considerably lesser accessibility compared to urban areas.
According to the report, automation of equipment will be a key driver for market growth. Automation of equipment improves speed and accuracy of blood analysis. Advances in automated cell counters have improved the speed and accuracy of blood analysis. Automated cell counters use optical light scattering and changes in electrical current. In modern automated hematology instruments, continuous improvements have enabled enumeration and evaluation of blood cells with great precision at low cost.
Further, the report states that the laws and regulations for the approval process for diagnostics devices vary across countries, which is a major challenge faced by vendors. In addition, any change in regulatory policies during the product development period could delay the entry of potential products into the market. Many developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea have strict regulations regarding the approval and marketing of diagnostics products.
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- EMD Millipore
- Thermo Fisher Scientific
- GE Healthcare
Other prominent vendors
- Agilent Technologies
- ChemoMetec A/S
- EKF Diagnostic
- ERBA Mannheim
- Horiba Scientific
- Logos Biosystem
- Olympus Life Science Solutions
- Worthington Biochemical
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Product segmentation
Part 07: Geographical segmentation
Part 08: Market drivers
Part 09: Impact of drivers
Part 10: Market challenges
Part 11: Impact of drivers and challenges
Part 12: Market trends
Part 13: Vendor landscape
Part 14: Key vendor analysis
Part 15: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/56w2mw/global_cell
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets